Urban Indian Education and Research Program, 65837-65845 [2020-22940]
Download as PDF
65837
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Regulation citation
§ 60.21: How to dispute
the accuracy of NPDB
information.
Administrative ...............
Total .......................
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
(rounded up)
619,001
3,264
1
1
619,001
3,264
.0003
.75
186
2,448
Request for Dispute Resolution
Entity Registration (Initial) ........
Entity Registration (Renewal &
Update).
State Licensing Board Data Request.
State Licensing Board Attestation.
Authorized Agent Attestation ....
Health Center Attestation .........
Hospital Attestation ...................
Medical Malpractice Payer,
Peer Review Organization, or
Private Accreditation Organization Attestation.
Other Eligible Entity Attestation
Corrective Action Plan (Entity)
Reconciling Missing Actions .....
Agent Registration (Initial) ........
Agent Registration (Renewal &
Update).
Electronic
Funds
Transfer
(EFT) Authorization.
Authorized Agent Designation ..
Account Discrepancy ................
New Administrator Request ......
Purchase Query Credits ...........
Education Request ...................
Account Balance Transfer ........
Missing Report From Query
Form.
74
3,484
13,245
1
1
1
74
3,484
13,245
8
1
.25
592
3,484
3,311
60
1
60
10.5
630
325
1
325
1
325
350
722
3,416
274
1
1
1
1
350
722
3,416
274
1
1
1
1
350
722
3,416
274
1,884
10
1,491
44
304
1
1
1
1
1
1,884
10
1,491
44
304
1
.08
.08
1
.08
1,884
1
119
44
24
644
1
644
.08
52
183
85
600
1,786
40
10
10
1
1
1
1
1
1
1
183
85
600
1786
40
10
10
.25
.25
.08
.08
.08
.08
.08
46
21
48
143
3
1
1
...................................................
7,101,274
........................
7,101,274
........................
347,294
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–22953 Filed 10–15–20; 8:45 am]
BILLING CODE 4165–15–P
Announcement Type: Competing
Supplement.
Funding Announcement Number:
HHS–2020–IHS–UIHP3–0002.
Assistance Listing (Catalog of Federal
Domestic Assistance or CFDA) Number:
93.193.
agreements for the Urban Indian
Education and Research Program. This
program is authorized under: The
Snyder Act, 25 U.S.C. 13; and the Public
Health Service Act, 42 U.S.C. 241(a)
Section 301(a). This supplement is
authorized and funded by the
Coronavirus Aid, Relief, and Economic
Security Act (the CARES Act), Public
Law (Pub. L.) 116–136. This program is
described in the Assistance Listings
located at https://beta.sam.gov (formerly
known as Catalog of Federal Domestic
Assistance) under 93.193.
Key Dates
Background
Application Deadline Date: November
6, 2020.
Earliest Anticipated Start Date:
November 25, 2020.
The Office of Urban Indian Health
Programs (OUIHP) oversees the
implementation of the Indian Health
Care Improvement Act (IHCIA)
provisions for making health care
services more accessible to Urban
Indians. Pursuant to those authorities,
the IHS enters into contracts and grants
with Urban Indian Organizations (UIOs)
for the provision of health care and
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Urban Indian Education and Research
Program
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS) is
accepting applications for a competing
supplement to current cooperative
VerDate Sep<11>2014
Total
responses
Continuous Query (automated)
Subject Statement and Dispute
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Form name
18:59 Oct 15, 2020
Jkt 253001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\16OCN1.SGM
16OCN1
65838
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
referral services for Urban Indians
residing in urban centers. Due to the
rapidly evolving nature of the
coronavirus (COVID–19) pandemic, this
program provides public health support
to focus on response, recovery, and
prevention in UIOs.
Purpose
The purpose of this program is to
fund an organization to provide COVID–
19 education and services in the
following five COVID–19 project areas:
(1) Public policy; (2) research and data;
(3) training and technical assistance; (4)
education, public relations, and
marketing; and (5) payment system
reform/monitoring regulations, and act
as a COVID–19 public health support
partner for OUIHP and UIOs funded
under the IHCIA.
II. Award Information
Funding Instrument—Cooperative
Agreement
Estimated Funds Available
The total funding identified for fiscal
year (FY) 2020 is approximately
$1,000,000. Award amount for the first
budget year is anticipated to be
$1,000,000. The funding available for
competing and subsequent continuation
awards issued under this announcement
is subject to the availability of
appropriations and budgetary priorities
of the Agency. The IHS is under no
obligation to make awards that are
selected for funding under this
announcement.
Anticipated Number of Awards
One award will be issued under this
program announcement.
Period of Performance
The period of performance is for two
years.
Cooperative Agreement
jbell on DSKJLSW7X2PROD with NOTICES
Cooperative agreements awarded by
the Department of Health and Human
Services (HHS) are administered under
the same policies as grants. However,
the funding agency, IHS, is anticipated
to have substantial programmatic
involvement in the project during the
entire award segment. Below is a
detailed description of the level of
involvement required of IHS.
Substantial Involvement Description for
Cooperative Agreement
In addition to the usual monitoring
and technical assistance provided under
the cooperative agreement, the IHS
OUIHP responsibilities shall include:
A. Assurance of the availability of
services from experienced OUIHP staff
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
to participate in the planning and
development of all phases of this
cooperative agreement;
B. Participation in, including the
planning of, any meetings conducted as
part of the five COVID–19 projects;
C. Assistance in establishing Federal
interagency contacts necessary for the
successful completion of tasks and
activities identified in the approved
scope of work;
D. Identification of organizations with
whom the awardee will be asked to
develop cooperative and collaborative
relationships;
E. Assisting the awardee to establish,
review, and update priorities for the five
COVID–19 projects conducted under
this cooperative agreement;
F. Assisting the awardee in
determining issues to be addressed
during the project period, sequence in
which they will be addressed, what
approaches and strategies will be used,
and how relevant information will be
transmitted to specified target audiences
and used to enhance core project
activities and advance the program; and
G. Assisting in identifying and
documenting the achievement of goals
and objectives for the five COVID–19
projects. This may include the
development of both process and
outcome measures and determining
timelines and data sources.
III. Eligibility Information
1. Eligibility
Eligibility for this ‘‘Competing
Supplement Announcement,’’ is limited
to the current awardees in the IHS
Urban Indian Health Education and
Research program. Applicants must
demonstrate that they have complied
with previous terms and conditions of
the IHS Urban Indian Health Education
and Research program. The applicant
must be a national organization with at
least ten years of experience providing
national awareness, visibility, advocacy,
education and outreach related to urban
Indian health care on a national scale.
Note: Please refer to Section IV.2
(Application and Submission
Information/Subsection 2, Content and
Form of Application Submission) for
additional proof of applicant status
documents required, such as a letter of
support from the organization’s Board of
Directors, proof of non-profit status, etc.
2. Cost Sharing or Matching
The IHS does not require matching
funds or cost sharing for grants or
cooperative agreements.
3. Other Requirements
Applications with budget requests
that exceed the highest dollar amount
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
outlined under Section II Award
Information, Estimated Funds Available,
or exceed the Period of Performance
outlined under Section II Award
Information, Period of Performance, will
be considered not responsive and will
not be reviewed. The Division of Grants
Management (DGM) will notify the
applicant.
Proof of Non-Profit Status
Organizations claiming non-profit
status must submit a current copy of the
501(c)(3) Certificate with the
application.
IV. Application and Submission
Information
1. Obtaining Application Materials
The application package and detailed
instructions for this announcement are
hosted on https://www.Grants.gov.
Please direct questions regarding the
application process to Mr. Paul Gettys at
(301) 443–2114 or (301) 443–5204.
2. Content and Form Application
Submission
The applicant must include the
project narrative as an attachment to the
application package. Mandatory
documents for all applicants include:
• Abstract (one page) summarizing
the project.
• Application forms:
1. SF–424, Application for Federal
Assistance.
2. SF–424A, Budget Information—
Non-Construction Programs.
3. SF–424B, Assurances—NonConstruction Programs.
• Project Narrative (not to exceed 20
pages). See Section IV.2.A Project
Narrative for instructions.
1. Background information on the
organization.
2. Proposed scope of work, objectives,
and activities that provide a description
of what the applicant plans to
accomplish.
• Budget Justification and Narrative
(not to exceed 5 pages). See Section
IV.2.B Budget Narrative for instructions.
• One-page Timeframe Chart.
• Letter of Support from
organization’s Board of Directors.
• 501(c)(3) Certificate.
• Biographical sketches for all Key
Personnel.
• Contractor/Consultant resumes or
qualifications and scope of work.
• Disclosure of Lobbying Activities
(SF–LLL).
• Certification Regarding Lobbying
(GG–Lobbying Form).
• Copy of current Negotiated Indirect
Cost rate (IDC) agreement (required in
order to receive IDC).
E:\FR\FM\16OCN1.SGM
16OCN1
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
• Organizational Chart.
• Documentation of current Office of
Management and Budget (OMB).
Financial Audit (if applicable).
Acceptable forms of documentation
include:
1. Email confirmation from Federal
Audit Clearinghouse (FAC) that audits
were submitted; or
2. Face sheets from audit reports.
Applicants can find these on the FAC
website: https://harvester.census.gov/
facdissem/Main.aspx.
Public Policy Requirements
All Federal public policies apply to
IHS grants and cooperative agreements
with the exception of the Discrimination
Policy.
jbell on DSKJLSW7X2PROD with NOTICES
Requirements for Project and Budget
Narratives
A. Project Narrative: This narrative
should be a separate document that is
no more than 20 pages and must: (1)
Have consecutively numbered pages; (2)
use black font 12 points or larger; (3) be
single-spaced; (4) and be formatted to fit
standard letter paper (81⁄2 x 11 inches).
Be sure to succinctly answer all
questions listed under the evaluation
criteria (refer to Section V.1, Evaluation
Criteria) and place all responses and
required information in the correct
section noted below or they will not be
considered or scored. If the narrative
exceeds the page limit, the application
will be considered not responsive and
not be reviewed. The 20-page limit for
the narrative does not include the
standard forms, line item budgets,
budget justifications and narratives,
and/or other appendix items.
There are four parts to the project
narrative: Part 1—Statement of Need;
Part 2—Program Information/Proposed
Approach; Part 3—Organizational
Capacity and Staffing/Administration;
and Part 4—Performance Measurement
Plan and Evaluation. See below for
additional details about what must be
included in the project narrative.
Part 1: Statement of Need
The applicant must provide COVID–
19 education and services under public
health support to focus on response,
recovery, and prevention in UIOs. The
five COVID–19 projects are: (1) Public
policy; (2) research and data; (3) training
and technical assistance; (4) education,
public relations, and marketing; and (5)
payment system reform/monitoring
regulations, and act as a COVID–19
public health support partner for OUIHP
and UIOs funded under the IHCIA.
This section will describe the UIOs
impacted by COVID–19 to be served by
this proposed project. Summarize the
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
overall need for assistance, including:
(1) Target population and its unmet
health needs; and (2) sociocultural
determinants of health and health
disparities impacting the urban Indian
population or communities served and
unmet. Demographic data should be
used and cited whenever possible to
support the information provided. Data
may come from a variety of qualitative
and quantitative sources. For example,
sources for quantitative data might
include epidemiologic data obtained
through legally permissible
arrangements from Tribal Epidemiology
Centers, IHS Area Offices, state data,
and/or national data from the Centers
for Disease Control and Prevention. This
list is not exhaustive.
Part 2: Program Information/Proposed
Approach
The applicant must have: (1) A
national information-sharing
infrastructure which will facilitate the
timely exchange of COVID–19
information between IHS and UIOs on
a broad scale; (2) a national perspective
on the needs of urban Indian
communities impacted by COVID–19 to
ensure the information developed and
disseminated is appropriate, useful, and
addresses the most pressing needs of
urban Indian communities; and (3) an
established relationship with UIOs to
foster open and honest participation by
urban Indian communities.
Describe the purpose of the proposed
project to COVID–19, including a clear
statement of goals and objectives.
Clearly state how proposed activities
address the needs detailed in the
statement of need. The applicant is
required to address all five COVID–19
projects in the project narrative and
address each project with a
corresponding time frame.
Part 3: Organizational Capacity and
Staffing/Administration
Describe the organizational capacity
for all five COVID–19 projects and the
organization’s experience working with
UIOs. Outline current staff and future
positions for the five program
components.
Part 4: Performance Measurement Plan
and Evaluation
Describe the plan to evaluate program
activities. Describe (the prior sentence
states that this paragraph will be about
the ‘‘evaluation plan’’) the expected
results and identify key performance
indicators on how program goals and
objectives will be met. Incorporate
process and outcome measures,
including documentation of lessons
learned.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
65839
Describe efforts to collect and report
project data that will support and
demonstrate grant activities for all five
COVID–19 projects. Data may come
from a variety of qualitative and
quantitative sources. For example,
sources for quantitative and qualitative
data might include surveys,
assessments, UIO satisfaction surveys,
and/or meeting evaluations. This list is
not exhaustive.
B. Budget and Budget Narrative:
Provide a budget narrative that explains
the amounts requested for each line
item of the budget. The budget narrative
should specifically describe how each
item will support the achievement of all
five COVID–19 projects. Be very careful
about showing how each item in the
‘‘Other’’ category is justified. For
subsequent budget years, the narrative
should highlight the changes from year
1 or clearly indicate that there are no
substantive budget changes during the
period of performance. Do NOT use the
budget narrative to expand the project
narrative.
3. Submission Dates and Times
Applications must be submitted
through Grants.gov by 11:59 p.m.
Eastern Daylight Time (EDT) on the
Application Deadline Date. Any
application received after the
application deadline will not be
accepted for review. Grants.gov will
notify the applicant via email if the
application is rejected.
If technical challenges arise and
assistance is required with the
application process, contact Grants.gov
Customer Support (see contact
information at https://www.Grants.gov).
If problems persist, contact Mr. Paul
Gettys (Paul.Gettys@ihs.gov), Acting
Director, DGM, by telephone at (301)
443–2114 or (301) 443–5204. Please be
sure to contact Mr. Gettys at least ten
days prior to the application deadline.
Please do not contact the DGM until you
have received a Grants.gov tracking
number. In the event you are not able
to obtain a tracking number, call the
DGM as soon as possible.
IHS will not acknowledge receipt of
applications.
4. Intergovernmental Review
Executive Order 12372 requiring
intergovernmental review is not
applicable to this program.
5. Funding Restrictions
• Pre-award costs are allowable up to
90 days before the start date of the
award provided the costs are otherwise
allowable if awarded. Pre-award costs
are incurred at the risk of the applicant.
E:\FR\FM\16OCN1.SGM
16OCN1
65840
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
• The available funds are inclusive of
direct and indirect costs.
• Only one cooperative agreement
may be awarded per applicant.
6. Electronic Submission Requirements
All applications must be submitted
via Grants.gov. Please use the https://
www.Grants.gov website to submit an
application. Find the application by
selecting the ‘‘Search Grants’’ link on
the homepage. Follow the instructions
for submitting an application under the
Package tab. No other method of
application submission is acceptable.
If the applicant cannot submit an
application through Grants.gov, a
waiver must be requested. Prior
approval must be requested and
obtained from Mr. Paul Gettys, Acting
Director, DGM. A written waiver request
must be sent to GrantsPolicy@ihs.gov
with a copy to Paul.Gettys@ihs.gov. The
waiver request must: (1) Be documented
in writing (emails are acceptable) before
submitting an application by some other
method, and (2) include clear
justification for the need to deviate from
the required application submission
process.
Once the waiver request has been
approved, the applicant will receive a
confirmation of approval email
containing submission instructions. A
copy of the written approval must be
included with the application that is
submitted to the DGM. Applications
that are submitted without a copy of the
signed waiver from the Acting Director
of the DGM will not be reviewed. The
Grants Management Officer of the DGM
will notify the applicant via email of
this decision. Applications submitted
under waiver must be received by the
DGM no later than 5:00 p.m., EDT, on
the Application Deadline Date. Late
applications will not be accepted for
processing. Applicants that do not
register for both the System for Award
Management (SAM) and Grants.gov
and/or fail to request timely assistance
with technical issues will not be
considered for a waiver to submit an
application via alternative method.
Please be aware of the following:
• Please search for the application
package in https://www.Grants.gov by
entering the Assistance Listing (CFDA)
number or the Funding Opportunity
Number. Both numbers are located in
the header of this announcement.
• If you experience technical
challenges while submitting your
application, please contact Grants.gov
Customer Support (see contact
information at https://www.Grants.gov).
• Upon contacting Grants.gov, obtain
a tracking number as proof of contact.
The tracking number is helpful if there
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
are technical issues that cannot be
resolved and a waiver from the agency
must be obtained.
• Applicants are strongly encouraged
not to wait until the deadline date to
begin the application process through
Grants.gov as the registration process for
SAM and Grants.gov could take up to
twenty working days.
• Please follow the instructions on
Grants.gov to include additional
documentation that may be requested by
this funding announcement.
• Applicants must comply with any
page limits described in this funding
announcement.
• After submitting the application,
the applicant will receive an automatic
acknowledgment from Grants.gov that
contains a Grants.gov tracking number.
The IHS will not notify the applicant
that the application has been received.
Dun and Bradstreet (D&B) Data
Universal Numbering System (DUNS)
Applicants and grantee organizations
are required to obtain a DUNS number
and maintain an active registration in
the SAM database. The DUNS number
is a unique 9-digit identification number
provided by D&B that uniquely
identifies each entity. The DUNS
number is site specific; therefore, each
distinct performance site may be
assigned a DUNS number. Obtaining a
DUNS number is easy, and there is no
charge. To obtain a DUNS number,
please access the request service
through https://fedgov.dnb.com/
webform, or call (866) 705–5711.
The Federal Funding Accountability
and Transparency Act of 2006, as
amended (‘‘Transparency Act’’),
requires all HHS recipients to report
information on sub-awards.
Accordingly, all IHS grantees must
notify potential first-tier sub-recipients
that no entity may receive a first-tier
sub-award unless the entity has
provided its DUNS number to the prime
grantee organization. This requirement
ensures the use of a universal identifier
to enhance the quality of information
available to the public pursuant to the
Transparency Act.
System for Award Management (SAM)
Organizations that are not registered
with SAM must have a DUNS number
first, then access the SAM online
registration through the SAM home page
at https://www.sam.gov/SAM/ (U.S.
organizations will also need to provide
an Employer Identification Number
from the Internal Revenue Service that
may take an additional 2–5 weeks to
become active). Please see SAM.gov for
details on the registration process and
timeline. Registration with the SAM is
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
free of charge, but can take several
weeks to process. Applicants may
register online at https://www.sam.gov/
SAM/.
Additional information on
implementing the Transparency Act,
including the specific requirements for
DUNS and SAM, are available on the
DGM Grants Management, Policy Topics
web page: https://www.ihs.gov/dgm/
policytopics/.
V. Application Review Information
Weights assigned to each section are
noted in parentheses. The 20-page
project narrative should include only
the first year of activities; information
for multi-year projects should be
included as an appendix. See ‘‘Multiyear Project Requirements’’ at the end of
this section for more information. The
narrative section should be written in a
manner that is clear to outside reviewers
unfamiliar with prior related activities
of the applicant. It should be well
organized, succinct, and contain all
information necessary for reviewers to
fully understand the project. Points will
be assigned to each evaluation criteria
adding up to a total of 100 possible
points. Points are assigned as follows:
1. Evaluation Criteria
A. Statement of Need (25 Points)
(1) Describe and document the target
population and its unmet needs for the
duration of the COVID–19 pandemic
and beyond, including, but not limited
to, the varying needs of different UIO
types, e.g., ambulatory, outreach and
referral, and residential treatment
centers.
(2) Based on the information and/or
data currently available, document the
need to implement, sustain, and
improve health care services offered to
urban Indians to address COVID–19
pandemic and beyond, including, but
not limited to, telehealth services and
other interactive telecommunication
systems. Data may come from a variety
of qualitative and quantitative sources.
For example, sources might include data
obtained through legally permissible
arrangements from Tribal Epidemiology
Centers, IHS Area Offices, state data,
and/or national data for the CDC. This
list is not exhaustive. Applicants may
submit other valid data, as appropriate.
(3) Based on available information
and/or data, describe COVID–19 service
gaps and other challenges related to the
needs of urban Indians such as
screening, detection, and monitoring.
Identify the source of the information
and/or data. Needed documentation
may come from a variety of qualitative
and quantitative sources.
E:\FR\FM\16OCN1.SGM
16OCN1
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
(4) Describe the need for COVID–19
data for planning, revenue generation,
and other operational systems to
improve health care services for urban
Indians.
B. Program Information/Proposed
Approach (30 Points)
Describe the purpose of the proposed
project to address the COVID–19
pandemic and beyond, including a clear
and concise statement of goals and
objectives. Provide a work plan for the
first year of the project period that
details expected key activities,
accomplishments, and includes
responsible staff for each of the five
COVID–19 projects. The project
narrative must address all five COVID–
19 projects of the program, see below:
(1) Public Policy: There is a need for
knowledge and expertise in a wide
range of COVID–19 public policy areas
for UIOs. Identify, evaluate, and
summarize public policy opportunities
and challenges impacting UIOs during
the COVID–19 pandemic. Evaluation
may include collecting and analyzing
public policy laws including activities,
characteristics, outcomes, and informed
decisions affecting UIOs.
Describe efforts to increase awareness
and actively seek support for the health
care needs of urban Indians impacted by
COVID–19. Describe efforts to engage
UIO leaders’ participation in policy
workgroups, Urban Confers, and
listening sessions to address COVID–19
pandemic and beyond.
(2) Research and Data: Data can be
used to help monitor and track the
spread of COVID–19, support better
understanding of the illness, and inform
and prepare UIOs. Describe the need to
collect and analyze COVID–19 health
disparities data, morbidity and mortality
data, and urban IHS cost data in order
to reduce urban Indian health
disparities. Incorporate process and
outcome measures. Identify, evaluate,
and summarize best practices from UIOs
during the COVID–19 pandemic.
Evaluation may include collecting and
analyzing program activities, issues,
policies, patient care, and safety.
Describe efforts to initiate or solidify
partnerships with UIOs, Tribal and
urban epidemiology centers, and other
data and research partners to improve
and increase COVID–19 research and
data on urban Indian health needs.
Identify, evaluate, and summarize
partnerships to increase COVID–19
research and data on urban Indian
needs. Evaluation may include
analyzing and collecting data from local,
Tribal, state, and Federal partnerships.
(3) Training and Technical
Assistance: Constant changes
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
surrounding COVID–19 demand the
need for continuous training and
technical assistance opportunities.
Describe the need for COVID–19
leadership training and technical
assistance to support UIO executive
directors/chief executive officers, board
of directors, and program staff (clinical
staff, administration, business office,
health information technology,
integrated behavioral health, etc.)
focusing on, but not limited to,
maintaining perspective in a crisis,
reinforcing guidance, obtaining data for
decision-making, reviewing recovery
assessments, establishing risks and
priorities, and managing medical
supplies and equipment.
(a) Further describe the need for
COVID–19 training and technical
assistance to support UIO
administration in facilitating change
management to improve understanding,
and encourage adoption for new
practices and maximize personal
resilience and professional performance.
(b) Describe the need for technical
assistance and training for UIOs to
develop integrated approaches for
contact tracing including protocols for
contact tracing of personnel or contact
with an individual with a confirmed or
probable COVID–19 status. Describe
training and technical assistance for
UIOs to create COVID–19 education and
training plans focused on continuity of
care for urban Indians, including
workforce support to maximize
employee retention and increase
readiness for future developments and
circumstances. Describe training and
technical assistance to assist UIOs with
organizing, developing, and/or refining
their COVID-related recovery
capabilities in accordance with Federal,
state, local, and other guidance.
Describe training and technical
assistance to assist UIOs to develop a
telehealth strategy to meet the postCOVID–19 environment of care.
(4) Education, Public Relations, and
Marketing: COVID–19 affected public
relations and marketing strategies
further delaying focus on urban Indian
health needs. Summarize the need to
market the UIOs through development
of national, regional, and local
marketing strategies and campaigns
during COVID–19 pandemic and
beyond.
(a) Describe efforts to increase
awareness of COVID–19 health care
needs of urban Indians. Describe efforts
to engage UIOs to participate in national
health campaigns related to COVID–19
prevention including vaccines. Describe
the need for enhanced communication
among local private and non-profit
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
65841
health care entities to increase COVID–
19 outreach efforts.
(b) Summarize the need to enhance
communication, interaction, and
coordination on policy and health care
reform activities to address COVID–19
by initiating and maintaining
partnerships and collaborative
relationships with other UIOs, national
Indian organizations, key state and local
health entities, and education and
public safety networks.
(c) Describe efforts to strengthen the
capacity of UIOs to work as a
community to improve COVID–19
knowledge sharing and promote
collaboration through learning from
success stories, sharing resources, and
driving activities together.
(5) Payment System Reform/
Monitoring Regulations: Urban Indian
health care systems need to manage the
health crisis and the economic crisis, in
light of the reduction in revenue, yet
surging demands for services.
(a) Describe services for UIOs to
address COVID–19, e.g., billing, health
information technology, CMS waivers,
regulations, etc. Describe efforts to
support UIOs’ efforts to diversify
funding and increase third party
reimbursement to ensure UIOs’
sustainability in COVID–19 pandemic
and beyond.
(b) Describe technical assistance,
training, and tools to be provided on
COVID–19 billing and coding best
practices, and negotiating with private
health insurers and health plans.
Describe efforts to establish and
enhance third party billing for UIOs to
address COVID–19 pandemic and
beyond.
(c) Describe the need to understand,
document, and analyze current and new
Federal COVID–19 related regulations
impacting UIOs for reimbursement.
Describe services to be provided to UIOs
on COVID–19 regulations and types of
regulatory activities needed to support
efforts to lessen the impact on UIOs’
financial and operational systems.
C. Organizational Capacity and Staffing/
Administration (15 Points)
(1) Describe the management
capability of the applicant and other
participating organizations in
administering similar projects.
(2) Identify staff to maintain open and
consistent communication with the IHS
program official on any financial or
programmatic barriers to meeting the
requirements of the award.
(3) Identify the department(s) and/or
division(s) that will administer all five
COVID–19 projects. Include a
description of these department(s) and/
or division(s), their functions, and their
E:\FR\FM\16OCN1.SGM
16OCN1
65842
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
placement within the applicant and
their direct link to management.
(4) Discuss the applicant’s experience
and capacity to provide culturally
appropriate and competent services to
UIOs and specific populations of focus
as described in this project.
(5) Describe the resources available
for the proposed project (e.g., facilities,
equipment, information technology
systems, and financial management
systems).
(6) Identify other organization(s) that
will participate in the proposed project.
Describe their roles and responsibilities
and demonstrate their commitment to
all five COVID–19 projects.
(7) Describe how project continuity
will be maintained if there is a change
in the operational environment (e.g.,
staff turnover, change in project
leadership, etc.) to ensure project
stability over the life of the grant.
(8) Provide a list of staff positions for
the project and other key personnel,
showing the role of each and their level
of effort and qualifications for all five
COVID–19 projects. Key personnel
include the Chief Executive Officer or
Executive Director, Chief Financial
Officer, Deputy Director, and
Information Officer.
(9) Demonstrate successful project
implementation for the level of effort
budgeted for the project staff and other
key staff.
(10) Include position descriptions as
attachments to the application for all
key personnel. Position descriptions
should not exceed one page each.
(11) For individuals who are currently
on staff, include a biographical sketch
with their name for each individual that
will be listed as the project staff and
other key positions. Describe the
experience of identified staff in all five
COVID–19 projects. Include each
biographical sketch as an attachment to
the project proposal/application.
Biographical sketches should not exceed
one page per staff member. Do not
include any of the following:
(a) Personally Identifiable Information
(social security number and date and
place or birth);
(b) Resumes; or
(c) Curriculum Vitae.
D. Performance Measurement Plan and
Evaluation (20 Points)
Describe key performance indicators
to monitor activities under all five
COVID–19 projects, explain measurable
progress toward program goals and
objectives by incorporating processes
and outcomes with quarterly timelines,
and advising on future program
decisions through evaluating success at
reaching targets over the 2-year project
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
period. Describe how issues affecting
progress will be addressed during the
project period and sequence in which
they will be addressed. Identify what
approaches and strategies will be used
to address issues and how relevant
information will be transmitted to
specified target audiences and used to
enhance project activities and advance
the program.
(1) Describe proposed COVID–19 data
collection efforts (performance measures
and associated data) and how you will
use the data to answer evaluation
questions. Evaluation questions may
include, were activities implemented as
planned? Did activities meet measurable
targets? Did activities reach target
population and how do you know?
This should include a logic model
with data collection method, data
source, data measurement tool,
identified staff for data management,
and data collection timeline.
(2) Identify key program partners and
describe how they will participate in the
implementation of the evaluation plan
(e.g., Tribal Epidemiology Centers,
universities, etc.).
(3) Describe how evaluating findings
will be used at the applicant level.
Discuss how data collected (e.g.,
performance measurement data) will be
used and shared by the key program
partners.
(4) Discuss any barriers or challenges
expected for implementing the plan,
collecting data (e.g., responding to
performance measures), and reporting
on evaluation results. Describe how
these potential barriers would be
overcome. In addition, applicants may
also describe other measures to be
developed or additional data sources
and data collection methods that
applicant will use.
E. Budget and Budget Narrative (10
Points)
(1) Include a line item budget for all
five COVID–19 projects including
expenditures identifying reasonable and
allowable costs necessary to accomplish
the goals and objectives as outlined in
the project narrative for budget year one
only.
(2) Provide a categorized budget for
all five COVID–19 projects. If it is
anticipated that there will be travel
costs to cover the cost of staff and UIO
leaders’ attendance at national advisory
committees and workgroups, the
applicant should ensure the associated
travel costs are included in the
categorized budget for public policy.
(3) Ensure that the budget and budget
narrative are aligned with the project
narrative. Questions to address include:
What resources are needed to
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
successfully carry out and manage the
five COVID–19 projects? What other
resources are available from the
organization? Will new staff be
recruited? Will outside contractors/
consultants be required?
(4) Include the total cost for any
outside contractors/consultants broken
down by activity within each core
project.
(5) If indirect costs are claimed,
indicate and apply the current
negotiated rate to the budget. Include a
copy of the current negotiated IDC rate
agreement in the appendix.
Multi-Year Project Requirements
Applications must include a brief
project narrative and budget (one
additional page per year) addressing the
developmental plans for each additional
year of the project. This attachment will
not count as part of the project narrative
or the budget narrative.
Additional documents can be
uploaded as Appendix Items in
Grants.gov:
• Work plan.
• Logic model.
• Timeline with proposed objectives.
• Position descriptions for key staff.
• Resumes of key staff that reflect
current duties.
• Consultant or contractor proposed
scope of work and letter of commitment
(if applicable).
• Current Indirect Cost Rate
Agreement.
• Organizational chart.
• Additional documents to support
narrative (i.e., data tables, key news
articles, etc.).
2. Review and Selection
Each application will be prescreened
for eligibility and completeness as
outlined in the funding announcement.
Applications that meet the eligibility
criteria shall be reviewed for merit by
the Objective Review Committee (ORC)
based on evaluation criteria. Incomplete
applications and applications that are
not responsive to the administrative
thresholds will not be referred to the
ORC and will not be funded. The
applicant will be notified of this
determination.
Applicants must address all program
requirements and provide all required
documentation.
3. Notifications of Disposition
All applicants will receive an
Executive Summary Statement from the
IHS OUIHP within 30 days of the
conclusion of the ORC outlining the
strengths and weaknesses of their
application. The summary statement
will be sent to the Authorizing Official
E:\FR\FM\16OCN1.SGM
16OCN1
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
identified on the face page (SF–424) of
the application.
A. Award Notices for Funded
Applications
The Notice of Award (NoA) is the
authorizing document for which funds
are dispersed to the approved entities
and reflects the amount of Federal funds
awarded, the purpose of the grant, the
terms and conditions of the award, the
effective date of the award, and the
budget/project period. Each entity
approved for funding must have a user
account in GrantSolutions in order to
retrieve the NoA. Please see the Agency
Contacts list in Section VII for the
systems contact information.
B. Approved but Unfunded
Applications
Approved applications not funded
due to lack of available funds will be
held for one year. If funding becomes
available during the course of the year,
the application may be reconsidered.
Note: Any correspondence other than
the official NoA executed by an IHS
grants management official announcing
to the project director that an award has
been made to their organization is not
an authorization to implement their
program on behalf of the IHS.
VI. Award Administration Information
jbell on DSKJLSW7X2PROD with NOTICES
1. Administrative Requirements
Cooperative agreements are
administered in accordance with the
following regulations and policies:
A. The criteria as outlined in this
program announcement.
B. Administrative Regulations for
Grants:
• Uniform Administrative
Requirements for HHS Awards, located
at 45 CFR part 75.
C. Grants Policy:
• HHS Grants Policy Statement,
Revised 01/07.
D. Cost Principles:
• Uniform Administrative
Requirements for HHS Awards, ‘‘Cost
Principles,’’ located at 45 CFR part 75,
subpart E.
E. Audit Requirements:
• Uniform Administrative
Requirements for HHS Awards, ‘‘Audit
Requirements,’’ located at 45 CFR part
75, subpart F.
2. Indirect Costs
This section applies to all recipients
that request reimbursement of indirect
costs (IDC) in their application budget.
In accordance with HHS Grants Policy
Statement, Part II–27, IHS requires
applicants to obtain a current IDC rate
agreement, and submit it to DGM, prior
to DGM issuing an award. The rate
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
agreement must be prepared in
accordance with the applicable cost
principles and guidance as provided by
the cognizant agency or office. A current
rate covers the applicable grant
activities under the current award’s
budget period. If the current rate
agreement is not on file with the DGM
at the time of award, the IDC portion of
the budget will be restricted. The
restrictions remain in place until the
current rate agreement is provided to
the DGM.
Available funds are inclusive of direct
and appropriate indirect costs.
Approved indirect funds are awarded as
part of the award amount, and no
additional funds will be provided.
Generally, IDC rates for IHS grantees
are negotiated with the Division of Cost
Allocation (DCA) https://rates.psc.gov/
or the Department of the Interior
(Interior Business Center) https://
ibc.doi.gov/ICS/tribal. For questions
regarding the indirect cost policy, please
call the Grants Management Specialist
listed under ‘‘Agency Contacts’’ or the
main DGM office at (301) 443–5204.
3. Reporting Requirements
The grantee must submit required
reports consistent with the applicable
deadlines. Failure to submit required
reports within the time allowed may
result in suspension or termination of
an active grant, withholding of
additional awards for the project, or
other enforcement actions such as
withholding of payments or converting
to the reimbursement method of
payment. Continued failure to submit
required reports may result in one or
both of the following: (1) The
imposition of special award provisions;
and (2) the non-funding or non-award of
other eligible projects or activities. This
requirement applies whether the
delinquency is attributable to the failure
of the awardee organization or the
individual responsible for preparation
of the reports. Per DGM policy, all
reports are required to be submitted
electronically by attaching them as a
‘‘Grant Note’’ in GrantSolutions.
Personnel responsible for submitting
reports will be required to obtain a login
and password for GrantSolutions. Please
see the Agency Contacts list in Section
VII for the systems contact information.
The reporting requirements for this
program are noted below.
A. Progress Reports
Program progress reports are required
quarterly, within 30 days after the
budget period ends (specific dates will
be listed in the NoA Terms and
Conditions). These reports must include
a brief comparison of actual
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
65843
accomplishments to the goals
established for the period, a summary of
progress to date or, if applicable,
provide sound justification for the lack
of progress, and other pertinent
information as required. A final report
must be submitted within 90 days of
expiration of the period of performance.
B. Financial Reports
Federal Financial Report (FFR or SF–
425), Cash Transaction Reports are due
30 days after the close of every calendar
quarter to the Payment Management
Services, HHS at https://pms.psc.gov.
The applicant is also requested to
upload a copy of the FFR (SF–425) into
our grants management system,
GrantSolutions. Failure to submit timely
reports may result in adverse award
actions blocking access to funds.
Grantees are responsible and
accountable for accurate information
being reported on all required reports:
The Progress Reports and Federal
Financial Report.
C. Federal Sub-Award Reporting System
(FSRS)
This award may be subject to the
Transparency Act sub-award and
executive compensation reporting
requirements of 2 CFR part 170.
The Transparency Act requires the
OMB to establish a single searchable
database, accessible to the public, with
information on financial assistance
awards made by Federal agencies. The
Transparency Act also includes a
requirement for recipients of Federal
grants to report information about firsttier sub-awards and executive
compensation under Federal assistance
awards.
IHS has implemented a Term of
Award into all IHS Standard Terms and
Conditions, NoAs and funding
announcements regarding the FSRS
reporting requirement. This IHS Term of
Award is applicable to all IHS grant and
cooperative agreements issued on or
after October 1, 2010, with a $25,000
sub-award obligation dollar threshold
met for any specific reporting period.
Additionally, all new (discretionary)
IHS awards (where the period of
performance is made up of more than
one budget period) and where: (1) The
period of performance start date was
October 1, 2010 or after, and (2) the
primary awardee will have a $25,000
sub-award obligation dollar threshold
during any specific reporting period
will be required to address the FSRS
reporting.
For the full IHS award term
implementing this requirement and
additional award applicability
information, visit the DGM Grants
E:\FR\FM\16OCN1.SGM
16OCN1
65844
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
Policy website at https://www.ihs.gov/
dgm/policytopics/.
D. Compliance With Executive Order
13166 Implementation of Services
Accessibility Provisions for All Grant
Application Packages and Funding
Opportunity Announcements
Recipients of Federal financial
assistance (FFA) from HHS must
administer their programs in
compliance with Federal civil rights
laws that prohibit discrimination on the
basis of race, color, national origin,
disability, age and, in some
circumstances, religion, conscience, and
sex. This includes ensuring programs
are accessible to persons with limited
English proficiency. The HHS Office for
Civil Rights provides guidance on
complying with civil rights laws
enforced by HHS. Please see https://
www.hhs.gov/civil-rights/for-providers/
provider-obligations/ and
https://www.hhs.gov/ocr/civilrights/
understanding/section1557/.
• Recipients of FFA must ensure that
their programs are accessible to persons
with limited English proficiency. HHS
provides guidance to recipients of FFA
on meeting their legal obligation to take
reasonable steps to provide meaningful
access to their programs by persons with
limited English proficiency. Please see
https://www.hhs.gov/civil-rights/forindividuals/special-topics/limitedenglish-proficiency/fact-sheet-guidance/
index.html and https://www.lep.gov. For
further guidance on providing culturally
and linguistically appropriate services,
recipients should review the National
Standards for Culturally and
Linguistically Appropriate Services in
Health and Health Care at https://
minorityhealth.hhs.gov/omh/
browse.aspx?lvl=2&lvlid=53.
• Recipients of FFA also have specific
legal obligations for serving qualified
individuals with disabilities. Please see
https://www.hhs.gov/ocr/civilrights/
understanding/disability/.
• HHS funded health and education
programs must be administered in an
environment free of sexual harassment.
Please see https://www.hhs.gov/civilrights/for-individuals/sexdiscrimination/; https://
www2.ed.gov/about/offices/list/ocr/
docs/shguide.html; and https://
www.eeoc.gov/eeoc/publications/fssex.cfm.
• Recipients of FFA must also
administer their programs in
compliance with applicable Federal
religious nondiscrimination laws and
applicable Federal conscience
protection and associated antidiscrimination laws. Collectively, these
laws prohibit exclusion, adverse
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
treatment, coercion, or other
discrimination against persons or
entities on the basis of their
consciences, religious beliefs, or moral
convictions. Please see https://
www.hhs.gov/conscience/conscienceprotections/ and https://
www.hhs.gov/conscience/religiousfreedom/.
Please contact the HHS Office for
Civil Rights for more information about
obligations and prohibitions under
Federal civil rights laws at https://
www.hhs.gov/ocr/about-us/contact-us/
index.html or call 1–800–368–1019 or
TDD 1–800–537–7697.
E. Federal Awardee Performance and
Integrity Information System (FAPIIS)
The IHS is required to review and
consider any information about the
applicant that is in the Federal Awardee
Performance and Integrity Information
System (FAPIIS), at https://
www.fapiis.gov, before making any
award in excess of the simplified
acquisition threshold (currently
$250,000) over the period of
performance. An applicant may review
and comment on any information about
itself that a Federal awarding agency
previously entered. IHS will consider
any comments by the applicant, in
addition to other information in FAPIIS
in making a judgment about the
applicant’s integrity, business ethics,
and record of performance under
Federal awards when completing the
review of risk posed by applicants as
described in 45 CFR 75.205.
As required by 45 CFR part 75
Appendix XII of the Uniform Guidance,
non-Federal entities (NFEs) are required
to disclose in FAPIIS any information
about criminal, civil, and administrative
proceedings, and/or affirm that there is
no new information to provide. This
applies to NFEs that receive Federal
awards (currently active grants,
cooperative agreements, and
procurement contracts) greater than
$10,000,000 for any period of time
during the period of performance of an
award/project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the
Uniform Guidance, and the HHS
implementing regulations at 45 CFR part
75, the IHS must require a non-Federal
entity or an applicant for a Federal
award to disclose, in a timely manner,
in writing to the IHS or pass-through
entity all violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award.
Submission is required for all
applicants and recipients, in writing, to
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
the IHS and to the HHS Office of
Inspector General all information
related to violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human
Services, Indian Health Service,
Division of Grants Management,
ATTN: Paul Gettys, Acting Director,
5600 Fishers Lane, Mail Stop: 09E70,
Rockville, MD 20857, (Include
‘‘Mandatory Grant Disclosures’’ in
subject line), Office: (301) 443–5204,
Fax: (301) 594–0899, Email:
Paul.Gettys@ihs.gov
And
U.S. Department of Health and Human
Services, Office of Inspector General,
ATTN: Mandatory Grant Disclosures,
Intake Coordinator, 330 Independence
Avenue SW, Cohen Building, Room
5527, Washington, DC 20201, URL:
https://oig.hhs.gov/fraud/reportfraud/ (Include ‘‘Mandatory Grant
Disclosures’’ in subject line), Fax:
(202) 205–0604 (Include ‘‘Mandatory
Grant Disclosures’’ in subject line) or
Email:
MandatoryGranteeDisclosures@
oig.hhs.gov
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371. Remedies
for noncompliance, including
suspension or debarment (see 2 CFR
parts 180 & 376).
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to: Shannon
Beyale, Health System Specialist, Office
of Urban Indian Health Programs, 5600
Fishers Lane, Mail Stop: 08E65D,
Rockville, MD 20857, Phone: (301) 945–
3657, Fax: (301) 443–8446, Email:
shannon.beyale@ihs.gov.
2. Questions on grants management
and fiscal matters may be directed to:
Donald Gooding, Grants Management
Specialist, 5600 Fishers Lane, Mail
Stop: 09E70, Rockville, MD 20857,
Phone: (301) 443–2298, Fax: (301) 594–
0899, Email: donald.gooding@ihs.gov.
3. Questions on systems matters may
be directed to: Paul Gettys, Acting
Director, 5600 Fishers Lane, Mail Stop:
09E70, Rockville, MD 20857, Phone:
(301) 443–2114; or the DGM main line
(301) 443–5204, Fax: (301) 594–0899,
Email: Paul.Gettys@ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all grant, cooperative
agreement and contract recipients to
provide a smoke-free workplace and
E:\FR\FM\16OCN1.SGM
16OCN1
Federal Register / Vol. 85, No. 201 / Friday, October 16, 2020 / Notices
promote the non-use of all tobacco
products. In addition, Public Law 103–
227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities
(or in some cases, any portion of the
facility) in which regular or routine
education, library, day care, health care,
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
protect and advance the physical and
mental health of the American people.
Michael D. Weahkee,
RADM, Assistant Surgeon General, U.S.
Public Health Service, Director, Indian Health
Service.
[FR Doc. 2020–22940 Filed 10–15–20; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Community Opioid Intervention Pilot
Projects
Announcement Type: New.
Funding Announcement Number:
HHS–2021–IHS–COIPP–0001.
Catalog of Federal Domestic
Assistance Number: 93.933.
Key Dates
Application Deadline Date: December
15, 2020.
Earliest Anticipated Start Date:
January 14, 2021.
jbell on DSKJLSW7X2PROD with NOTICES
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS) is
accepting applications for grants for the
Community Opioid Intervention Pilot
Projects (COIPP). This program was first
established by the Consolidated
Appropriations Act of 2019, (Pub. L.
116–6) and the accompanying
Conference Report, H. Rpt. 116–9. IHS
received a new appropriation of $10
million in FY 2019 to better combat the
opioid epidemic by creating a pilot
program to address the opioid epidemic
in Indian Country to award grants that
support the development,
documentation, and sharing of locally
designed and culturally appropriate
prevention, treatment, recovery, and
aftercare services for mental health and
substance use disorders in American
Indian and Alaska Native communities.
The IHS received a second
appropriation of $10 million in the FY
2020 Further Consolidated
Appropriations Act (Pub. L. 116–94).
IHS will provide technical assistance to
grantees to collect and evaluate
performance of the pilot program. This
VerDate Sep<11>2014
18:59 Oct 15, 2020
Jkt 253001
program is authorized under the
authority of 25 U.S.C. 13, the Snyder
Act, and the Indian Health Care
Improvement Act, 25 U.S.C. 1601–1683.
This program is described in the
Assistance Listings located at https://
beta.sam.gov (formerly known as
Catalog of Federal Domestic Assistance)
under 93.933.
Background
The impact of the opioid crisis on
American Indian and Alaska Native (AI/
AN) populations is immense. The rate of
drug overdose deaths among AI/ANs is
above the national average. The Centers
for Disease Control and Prevention
(CDC) data indicate that AI/ANs had the
second highest overdose death rates
from all opioids in 2017 (15.7 deaths/
100,000 population) among racial/
ethnic groups in the United States. AI/
ANs had the second highest overdose
death rates from heroin (5.2 deaths/
100,000 population), third highest from
synthetic opioids (6.5 deaths/100,000
population), and the highest rate from
prescription opioids (7.2 deaths/100,000
population) during 2016–2017. The
overall rate of overdose deaths for AI/
ANs increased by 13% during 2015–
2017. These numbers may be
underestimated for the AI/AN
population due to racial
misclassification on death certificates as
recently published by the CDC
Morbidity and Mortality Weekly Report,
resulting in inaccurate public health
data for the AI/AN population.1
The family remains the primary
source of attachment, nurturing, and
socialization for humans in our current
society, and opioid use disorder (OUD)
has had a devastating effect on families.
The impact of substance use disorders
(SUDs) on the family and individual
family members merits attention. Each
family and each family member is
uniquely affected by the individual
using substances including having
unmet developmental needs, impaired
attachment, economic hardship, legal
problems, emotional distress, and
sometimes violence being perpetrated
against them. For children there is also
an increased risk of developing a SUD
themselves. Thus, treating only the
individual with the active disease of
addiction is limited in effectiveness.
This grant aims to address the
increasing number of infants born to
mothers with a SUD, and children who
reside in homes with parents with OUD
by awarding at least six grant sites to
programs that focus on maternal and
child health issues.
1 Joshi, Weiser, & Warren-Mears, Dec 2018. CDC
Morbidity and Mortality Weekly Report.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
65845
In keeping with the IHS policy stating
that Tribal consultation occurs when a
new or revised policy or program is
proposed, IHS held a tribal consultation
and Urban confer process on the
development of a new opioid grant
program from June 21, 2019 to
September 3, 2019. Formal sessions
were held to allow for feedback on
priorities, methodologies, and desired
outcomes to be used in the selection and
award process. IHS received a total of
119 comments from all 12 IHS areas.
The comments received represented a
wide range of suggestions but several
themes emerged, most notably the
importance of allowing flexibility in
program design and focus areas.
Respondents also requested that IHS
ensure that programs include: Culturally
responsive approaches to addressing the
opioid crisis; a focus on education and
training for communities on opioids and
treatment options; and a high priority
area of focus on serving addicted
pregnant women and infants preexposed to opioids. IHS published a
Dear Tribal Leader Letter and
Consultation and Conference Summary
Report in the IHS Newsroom on April
3, 2020. https://www.ihs.gov/sites/
newsroom/themes/responsive2017/
display_objects/documents/2020_
Letters/DTLL_DUIOLL_OGPP_
04032020.pdf.
Purpose
The purpose of this IHS grant is to
address the opioid crisis in AI/AN
communities by developing and
expanding community education and
awareness of prevention, treatment and/
or recovery activities for opioid misuse
and opioid use disorder. The intent is to
increase knowledge and use of
culturally appropriate interventions and
to encourage an increased use of
medication-assisted treatment (MAT).
This program will support Tribal and
Urban Indian communities in their
effort to provide prevention, treatment,
and recovery services to address the
impact of the opioid crisis within their
communities. Each application for the
COIPP will be required to address the
following objectives:
1. Increase public awareness and
education about culturally-appropriate
and family-centered opioid prevention,
treatment, and recovery practices and
programs in AI/AN communities.
2. Create comprehensive support
teams to strengthen and empower AI/
AN families in addressing the opioid
crisis in Tribal or Urban Indian
communities.
3. Reduce unmet treatment needs and
opioid overdose related deaths through
the use of MAT.
E:\FR\FM\16OCN1.SGM
16OCN1
Agencies
[Federal Register Volume 85, Number 201 (Friday, October 16, 2020)]
[Notices]
[Pages 65837-65845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22940]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Urban Indian Education and Research Program
Announcement Type: Competing Supplement.
Funding Announcement Number: HHS-2020-IHS-UIHP3-0002.
Assistance Listing (Catalog of Federal Domestic Assistance or CFDA)
Number: 93.193.
Key Dates
Application Deadline Date: November 6, 2020.
Earliest Anticipated Start Date: November 25, 2020.
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS) is accepting applications for a
competing supplement to current cooperative agreements for the Urban
Indian Education and Research Program. This program is authorized
under: The Snyder Act, 25 U.S.C. 13; and the Public Health Service Act,
42 U.S.C. 241(a) Section 301(a). This supplement is authorized and
funded by the Coronavirus Aid, Relief, and Economic Security Act (the
CARES Act), Public Law (Pub. L.) 116-136. This program is described in
the Assistance Listings located at https://beta.sam.gov (formerly known
as Catalog of Federal Domestic Assistance) under 93.193.
Background
The Office of Urban Indian Health Programs (OUIHP) oversees the
implementation of the Indian Health Care Improvement Act (IHCIA)
provisions for making health care services more accessible to Urban
Indians. Pursuant to those authorities, the IHS enters into contracts
and grants with Urban Indian Organizations (UIOs) for the provision of
health care and
[[Page 65838]]
referral services for Urban Indians residing in urban centers. Due to
the rapidly evolving nature of the coronavirus (COVID-19) pandemic,
this program provides public health support to focus on response,
recovery, and prevention in UIOs.
Purpose
The purpose of this program is to fund an organization to provide
COVID-19 education and services in the following five COVID-19 project
areas: (1) Public policy; (2) research and data; (3) training and
technical assistance; (4) education, public relations, and marketing;
and (5) payment system reform/monitoring regulations, and act as a
COVID-19 public health support partner for OUIHP and UIOs funded under
the IHCIA.
II. Award Information
Funding Instrument--Cooperative Agreement
Estimated Funds Available
The total funding identified for fiscal year (FY) 2020 is
approximately $1,000,000. Award amount for the first budget year is
anticipated to be $1,000,000. The funding available for competing and
subsequent continuation awards issued under this announcement is
subject to the availability of appropriations and budgetary priorities
of the Agency. The IHS is under no obligation to make awards that are
selected for funding under this announcement.
Anticipated Number of Awards
One award will be issued under this program announcement.
Period of Performance
The period of performance is for two years.
Cooperative Agreement
Cooperative agreements awarded by the Department of Health and
Human Services (HHS) are administered under the same policies as
grants. However, the funding agency, IHS, is anticipated to have
substantial programmatic involvement in the project during the entire
award segment. Below is a detailed description of the level of
involvement required of IHS.
Substantial Involvement Description for Cooperative Agreement
In addition to the usual monitoring and technical assistance
provided under the cooperative agreement, the IHS OUIHP
responsibilities shall include:
A. Assurance of the availability of services from experienced OUIHP
staff to participate in the planning and development of all phases of
this cooperative agreement;
B. Participation in, including the planning of, any meetings
conducted as part of the five COVID-19 projects;
C. Assistance in establishing Federal interagency contacts
necessary for the successful completion of tasks and activities
identified in the approved scope of work;
D. Identification of organizations with whom the awardee will be
asked to develop cooperative and collaborative relationships;
E. Assisting the awardee to establish, review, and update
priorities for the five COVID-19 projects conducted under this
cooperative agreement;
F. Assisting the awardee in determining issues to be addressed
during the project period, sequence in which they will be addressed,
what approaches and strategies will be used, and how relevant
information will be transmitted to specified target audiences and used
to enhance core project activities and advance the program; and
G. Assisting in identifying and documenting the achievement of
goals and objectives for the five COVID-19 projects. This may include
the development of both process and outcome measures and determining
timelines and data sources.
III. Eligibility Information
1. Eligibility
Eligibility for this ``Competing Supplement Announcement,'' is
limited to the current awardees in the IHS Urban Indian Health
Education and Research program. Applicants must demonstrate that they
have complied with previous terms and conditions of the IHS Urban
Indian Health Education and Research program. The applicant must be a
national organization with at least ten years of experience providing
national awareness, visibility, advocacy, education and outreach
related to urban Indian health care on a national scale.
Note: Please refer to Section IV.2 (Application and Submission
Information/Subsection 2, Content and Form of Application Submission)
for additional proof of applicant status documents required, such as a
letter of support from the organization's Board of Directors, proof of
non-profit status, etc.
2. Cost Sharing or Matching
The IHS does not require matching funds or cost sharing for grants
or cooperative agreements.
3. Other Requirements
Applications with budget requests that exceed the highest dollar
amount outlined under Section II Award Information, Estimated Funds
Available, or exceed the Period of Performance outlined under Section
II Award Information, Period of Performance, will be considered not
responsive and will not be reviewed. The Division of Grants Management
(DGM) will notify the applicant.
Proof of Non-Profit Status
Organizations claiming non-profit status must submit a current copy
of the 501(c)(3) Certificate with the application.
IV. Application and Submission Information
1. Obtaining Application Materials
The application package and detailed instructions for this
announcement are hosted on https://www.Grants.gov.
Please direct questions regarding the application process to Mr.
Paul Gettys at (301) 443-2114 or (301) 443-5204.
2. Content and Form Application Submission
The applicant must include the project narrative as an attachment
to the application package. Mandatory documents for all applicants
include:
Abstract (one page) summarizing the project.
Application forms:
1. SF-424, Application for Federal Assistance.
2. SF-424A, Budget Information--Non-Construction Programs.
3. SF-424B, Assurances--Non-Construction Programs.
Project Narrative (not to exceed 20 pages). See Section
IV.2.A Project Narrative for instructions.
1. Background information on the organization.
2. Proposed scope of work, objectives, and activities that provide
a description of what the applicant plans to accomplish.
Budget Justification and Narrative (not to exceed 5
pages). See Section IV.2.B Budget Narrative for instructions.
One-page Timeframe Chart.
Letter of Support from organization's Board of Directors.
501(c)(3) Certificate.
Biographical sketches for all Key Personnel.
Contractor/Consultant resumes or qualifications and scope
of work.
Disclosure of Lobbying Activities (SF-LLL).
Certification Regarding Lobbying (GG-Lobbying Form).
Copy of current Negotiated Indirect Cost rate (IDC)
agreement (required in order to receive IDC).
[[Page 65839]]
Organizational Chart.
Documentation of current Office of Management and Budget
(OMB). Financial Audit (if applicable).
Acceptable forms of documentation include:
1. Email confirmation from Federal Audit Clearinghouse (FAC) that
audits were submitted; or
2. Face sheets from audit reports. Applicants can find these on the
FAC website: https://harvester.census.gov/facdissem/Main.aspx.
Public Policy Requirements
All Federal public policies apply to IHS grants and cooperative
agreements with the exception of the Discrimination Policy.
Requirements for Project and Budget Narratives
A. Project Narrative: This narrative should be a separate document
that is no more than 20 pages and must: (1) Have consecutively numbered
pages; (2) use black font 12 points or larger; (3) be single-spaced;
(4) and be formatted to fit standard letter paper (8\1/2\ x 11 inches).
Be sure to succinctly answer all questions listed under the
evaluation criteria (refer to Section V.1, Evaluation Criteria) and
place all responses and required information in the correct section
noted below or they will not be considered or scored. If the narrative
exceeds the page limit, the application will be considered not
responsive and not be reviewed. The 20-page limit for the narrative
does not include the standard forms, line item budgets, budget
justifications and narratives, and/or other appendix items.
There are four parts to the project narrative: Part 1--Statement of
Need; Part 2--Program Information/Proposed Approach; Part 3--
Organizational Capacity and Staffing/Administration; and Part 4--
Performance Measurement Plan and Evaluation. See below for additional
details about what must be included in the project narrative.
Part 1: Statement of Need
The applicant must provide COVID-19 education and services under
public health support to focus on response, recovery, and prevention in
UIOs. The five COVID-19 projects are: (1) Public policy; (2) research
and data; (3) training and technical assistance; (4) education, public
relations, and marketing; and (5) payment system reform/monitoring
regulations, and act as a COVID-19 public health support partner for
OUIHP and UIOs funded under the IHCIA.
This section will describe the UIOs impacted by COVID-19 to be
served by this proposed project. Summarize the overall need for
assistance, including: (1) Target population and its unmet health
needs; and (2) sociocultural determinants of health and health
disparities impacting the urban Indian population or communities served
and unmet. Demographic data should be used and cited whenever possible
to support the information provided. Data may come from a variety of
qualitative and quantitative sources. For example, sources for
quantitative data might include epidemiologic data obtained through
legally permissible arrangements from Tribal Epidemiology Centers, IHS
Area Offices, state data, and/or national data from the Centers for
Disease Control and Prevention. This list is not exhaustive.
Part 2: Program Information/Proposed Approach
The applicant must have: (1) A national information-sharing
infrastructure which will facilitate the timely exchange of COVID-19
information between IHS and UIOs on a broad scale; (2) a national
perspective on the needs of urban Indian communities impacted by COVID-
19 to ensure the information developed and disseminated is appropriate,
useful, and addresses the most pressing needs of urban Indian
communities; and (3) an established relationship with UIOs to foster
open and honest participation by urban Indian communities.
Describe the purpose of the proposed project to COVID-19, including
a clear statement of goals and objectives. Clearly state how proposed
activities address the needs detailed in the statement of need. The
applicant is required to address all five COVID-19 projects in the
project narrative and address each project with a corresponding time
frame.
Part 3: Organizational Capacity and Staffing/Administration
Describe the organizational capacity for all five COVID-19 projects
and the organization's experience working with UIOs. Outline current
staff and future positions for the five program components.
Part 4: Performance Measurement Plan and Evaluation
Describe the plan to evaluate program activities. Describe (the
prior sentence states that this paragraph will be about the
``evaluation plan'') the expected results and identify key performance
indicators on how program goals and objectives will be met. Incorporate
process and outcome measures, including documentation of lessons
learned.
Describe efforts to collect and report project data that will
support and demonstrate grant activities for all five COVID-19
projects. Data may come from a variety of qualitative and quantitative
sources. For example, sources for quantitative and qualitative data
might include surveys, assessments, UIO satisfaction surveys, and/or
meeting evaluations. This list is not exhaustive.
B. Budget and Budget Narrative: Provide a budget narrative that
explains the amounts requested for each line item of the budget. The
budget narrative should specifically describe how each item will
support the achievement of all five COVID-19 projects. Be very careful
about showing how each item in the ``Other'' category is justified. For
subsequent budget years, the narrative should highlight the changes
from year 1 or clearly indicate that there are no substantive budget
changes during the period of performance. Do NOT use the budget
narrative to expand the project narrative.
3. Submission Dates and Times
Applications must be submitted through Grants.gov by 11:59 p.m.
Eastern Daylight Time (EDT) on the Application Deadline Date. Any
application received after the application deadline will not be
accepted for review. Grants.gov will notify the applicant via email if
the application is rejected.
If technical challenges arise and assistance is required with the
application process, contact Grants.gov Customer Support (see contact
information at https://www.Grants.gov). If problems persist, contact
Mr. Paul Gettys ([email protected]), Acting Director, DGM, by
telephone at (301) 443-2114 or (301) 443-5204. Please be sure to
contact Mr. Gettys at least ten days prior to the application deadline.
Please do not contact the DGM until you have received a Grants.gov
tracking number. In the event you are not able to obtain a tracking
number, call the DGM as soon as possible.
IHS will not acknowledge receipt of applications.
4. Intergovernmental Review
Executive Order 12372 requiring intergovernmental review is not
applicable to this program.
5. Funding Restrictions
Pre-award costs are allowable up to 90 days before the
start date of the award provided the costs are otherwise allowable if
awarded. Pre-award costs are incurred at the risk of the applicant.
[[Page 65840]]
The available funds are inclusive of direct and indirect
costs.
Only one cooperative agreement may be awarded per
applicant.
6. Electronic Submission Requirements
All applications must be submitted via Grants.gov. Please use the
https://www.Grants.gov website to submit an application. Find the
application by selecting the ``Search Grants'' link on the homepage.
Follow the instructions for submitting an application under the Package
tab. No other method of application submission is acceptable.
If the applicant cannot submit an application through Grants.gov, a
waiver must be requested. Prior approval must be requested and obtained
from Mr. Paul Gettys, Acting Director, DGM. A written waiver request
must be sent to [email protected] with a copy to
[email protected]. The waiver request must: (1) Be documented in
writing (emails are acceptable) before submitting an application by
some other method, and (2) include clear justification for the need to
deviate from the required application submission process.
Once the waiver request has been approved, the applicant will
receive a confirmation of approval email containing submission
instructions. A copy of the written approval must be included with the
application that is submitted to the DGM. Applications that are
submitted without a copy of the signed waiver from the Acting Director
of the DGM will not be reviewed. The Grants Management Officer of the
DGM will notify the applicant via email of this decision. Applications
submitted under waiver must be received by the DGM no later than 5:00
p.m., EDT, on the Application Deadline Date. Late applications will not
be accepted for processing. Applicants that do not register for both
the System for Award Management (SAM) and Grants.gov and/or fail to
request timely assistance with technical issues will not be considered
for a waiver to submit an application via alternative method.
Please be aware of the following:
Please search for the application package in https://www.Grants.gov by entering the Assistance Listing (CFDA) number or the
Funding Opportunity Number. Both numbers are located in the header of
this announcement.
If you experience technical challenges while submitting
your application, please contact Grants.gov Customer Support (see
contact information at https://www.Grants.gov).
Upon contacting Grants.gov, obtain a tracking number as
proof of contact. The tracking number is helpful if there are technical
issues that cannot be resolved and a waiver from the agency must be
obtained.
Applicants are strongly encouraged not to wait until the
deadline date to begin the application process through Grants.gov as
the registration process for SAM and Grants.gov could take up to twenty
working days.
Please follow the instructions on Grants.gov to include
additional documentation that may be requested by this funding
announcement.
Applicants must comply with any page limits described in
this funding announcement.
After submitting the application, the applicant will
receive an automatic acknowledgment from Grants.gov that contains a
Grants.gov tracking number. The IHS will not notify the applicant that
the application has been received.
Dun and Bradstreet (D&B) Data Universal Numbering System (DUNS)
Applicants and grantee organizations are required to obtain a DUNS
number and maintain an active registration in the SAM database. The
DUNS number is a unique 9-digit identification number provided by D&B
that uniquely identifies each entity. The DUNS number is site specific;
therefore, each distinct performance site may be assigned a DUNS
number. Obtaining a DUNS number is easy, and there is no charge. To
obtain a DUNS number, please access the request service through https://fedgov.dnb.com/webform, or call (866) 705-5711.
The Federal Funding Accountability and Transparency Act of 2006, as
amended (``Transparency Act''), requires all HHS recipients to report
information on sub-awards. Accordingly, all IHS grantees must notify
potential first-tier sub-recipients that no entity may receive a first-
tier sub-award unless the entity has provided its DUNS number to the
prime grantee organization. This requirement ensures the use of a
universal identifier to enhance the quality of information available to
the public pursuant to the Transparency Act.
System for Award Management (SAM)
Organizations that are not registered with SAM must have a DUNS
number first, then access the SAM online registration through the SAM
home page at https://www.sam.gov/SAM/ (U.S. organizations will also
need to provide an Employer Identification Number from the Internal
Revenue Service that may take an additional 2-5 weeks to become
active). Please see SAM.gov for details on the registration process and
timeline. Registration with the SAM is free of charge, but can take
several weeks to process. Applicants may register online at https://www.sam.gov/SAM/.
Additional information on implementing the Transparency Act,
including the specific requirements for DUNS and SAM, are available on
the DGM Grants Management, Policy Topics web page: https://www.ihs.gov/dgm/policytopics/.
V. Application Review Information
Weights assigned to each section are noted in parentheses. The 20-
page project narrative should include only the first year of
activities; information for multi-year projects should be included as
an appendix. See ``Multi-year Project Requirements'' at the end of this
section for more information. The narrative section should be written
in a manner that is clear to outside reviewers unfamiliar with prior
related activities of the applicant. It should be well organized,
succinct, and contain all information necessary for reviewers to fully
understand the project. Points will be assigned to each evaluation
criteria adding up to a total of 100 possible points. Points are
assigned as follows:
1. Evaluation Criteria
A. Statement of Need (25 Points)
(1) Describe and document the target population and its unmet needs
for the duration of the COVID-19 pandemic and beyond, including, but
not limited to, the varying needs of different UIO types, e.g.,
ambulatory, outreach and referral, and residential treatment centers.
(2) Based on the information and/or data currently available,
document the need to implement, sustain, and improve health care
services offered to urban Indians to address COVID-19 pandemic and
beyond, including, but not limited to, telehealth services and other
interactive telecommunication systems. Data may come from a variety of
qualitative and quantitative sources. For example, sources might
include data obtained through legally permissible arrangements from
Tribal Epidemiology Centers, IHS Area Offices, state data, and/or
national data for the CDC. This list is not exhaustive. Applicants may
submit other valid data, as appropriate.
(3) Based on available information and/or data, describe COVID-19
service gaps and other challenges related to the needs of urban Indians
such as screening, detection, and monitoring. Identify the source of
the information and/or data. Needed documentation may come from a
variety of qualitative and quantitative sources.
[[Page 65841]]
(4) Describe the need for COVID-19 data for planning, revenue
generation, and other operational systems to improve health care
services for urban Indians.
B. Program Information/Proposed Approach (30 Points)
Describe the purpose of the proposed project to address the COVID-
19 pandemic and beyond, including a clear and concise statement of
goals and objectives. Provide a work plan for the first year of the
project period that details expected key activities, accomplishments,
and includes responsible staff for each of the five COVID-19 projects.
The project narrative must address all five COVID-19 projects of the
program, see below:
(1) Public Policy: There is a need for knowledge and expertise in a
wide range of COVID-19 public policy areas for UIOs. Identify,
evaluate, and summarize public policy opportunities and challenges
impacting UIOs during the COVID-19 pandemic. Evaluation may include
collecting and analyzing public policy laws including activities,
characteristics, outcomes, and informed decisions affecting UIOs.
Describe efforts to increase awareness and actively seek support
for the health care needs of urban Indians impacted by COVID-19.
Describe efforts to engage UIO leaders' participation in policy
workgroups, Urban Confers, and listening sessions to address COVID-19
pandemic and beyond.
(2) Research and Data: Data can be used to help monitor and track
the spread of COVID-19, support better understanding of the illness,
and inform and prepare UIOs. Describe the need to collect and analyze
COVID-19 health disparities data, morbidity and mortality data, and
urban IHS cost data in order to reduce urban Indian health disparities.
Incorporate process and outcome measures. Identify, evaluate, and
summarize best practices from UIOs during the COVID-19 pandemic.
Evaluation may include collecting and analyzing program activities,
issues, policies, patient care, and safety.
Describe efforts to initiate or solidify partnerships with UIOs,
Tribal and urban epidemiology centers, and other data and research
partners to improve and increase COVID-19 research and data on urban
Indian health needs. Identify, evaluate, and summarize partnerships to
increase COVID-19 research and data on urban Indian needs. Evaluation
may include analyzing and collecting data from local, Tribal, state,
and Federal partnerships.
(3) Training and Technical Assistance: Constant changes surrounding
COVID-19 demand the need for continuous training and technical
assistance opportunities. Describe the need for COVID-19 leadership
training and technical assistance to support UIO executive directors/
chief executive officers, board of directors, and program staff
(clinical staff, administration, business office, health information
technology, integrated behavioral health, etc.) focusing on, but not
limited to, maintaining perspective in a crisis, reinforcing guidance,
obtaining data for decision-making, reviewing recovery assessments,
establishing risks and priorities, and managing medical supplies and
equipment.
(a) Further describe the need for COVID-19 training and technical
assistance to support UIO administration in facilitating change
management to improve understanding, and encourage adoption for new
practices and maximize personal resilience and professional
performance.
(b) Describe the need for technical assistance and training for
UIOs to develop integrated approaches for contact tracing including
protocols for contact tracing of personnel or contact with an
individual with a confirmed or probable COVID-19 status. Describe
training and technical assistance for UIOs to create COVID-19 education
and training plans focused on continuity of care for urban Indians,
including workforce support to maximize employee retention and increase
readiness for future developments and circumstances. Describe training
and technical assistance to assist UIOs with organizing, developing,
and/or refining their COVID-related recovery capabilities in accordance
with Federal, state, local, and other guidance. Describe training and
technical assistance to assist UIOs to develop a telehealth strategy to
meet the post-COVID-19 environment of care.
(4) Education, Public Relations, and Marketing: COVID-19 affected
public relations and marketing strategies further delaying focus on
urban Indian health needs. Summarize the need to market the UIOs
through development of national, regional, and local marketing
strategies and campaigns during COVID-19 pandemic and beyond.
(a) Describe efforts to increase awareness of COVID-19 health care
needs of urban Indians. Describe efforts to engage UIOs to participate
in national health campaigns related to COVID-19 prevention including
vaccines. Describe the need for enhanced communication among local
private and non-profit health care entities to increase COVID-19
outreach efforts.
(b) Summarize the need to enhance communication, interaction, and
coordination on policy and health care reform activities to address
COVID-19 by initiating and maintaining partnerships and collaborative
relationships with other UIOs, national Indian organizations, key state
and local health entities, and education and public safety networks.
(c) Describe efforts to strengthen the capacity of UIOs to work as
a community to improve COVID-19 knowledge sharing and promote
collaboration through learning from success stories, sharing resources,
and driving activities together.
(5) Payment System Reform/Monitoring Regulations: Urban Indian
health care systems need to manage the health crisis and the economic
crisis, in light of the reduction in revenue, yet surging demands for
services.
(a) Describe services for UIOs to address COVID-19, e.g., billing,
health information technology, CMS waivers, regulations, etc. Describe
efforts to support UIOs' efforts to diversify funding and increase
third party reimbursement to ensure UIOs' sustainability in COVID-19
pandemic and beyond.
(b) Describe technical assistance, training, and tools to be
provided on COVID-19 billing and coding best practices, and negotiating
with private health insurers and health plans. Describe efforts to
establish and enhance third party billing for UIOs to address COVID-19
pandemic and beyond.
(c) Describe the need to understand, document, and analyze current
and new Federal COVID-19 related regulations impacting UIOs for
reimbursement. Describe services to be provided to UIOs on COVID-19
regulations and types of regulatory activities needed to support
efforts to lessen the impact on UIOs' financial and operational
systems.
C. Organizational Capacity and Staffing/Administration (15 Points)
(1) Describe the management capability of the applicant and other
participating organizations in administering similar projects.
(2) Identify staff to maintain open and consistent communication
with the IHS program official on any financial or programmatic barriers
to meeting the requirements of the award.
(3) Identify the department(s) and/or division(s) that will
administer all five COVID-19 projects. Include a description of these
department(s) and/or division(s), their functions, and their
[[Page 65842]]
placement within the applicant and their direct link to management.
(4) Discuss the applicant's experience and capacity to provide
culturally appropriate and competent services to UIOs and specific
populations of focus as described in this project.
(5) Describe the resources available for the proposed project
(e.g., facilities, equipment, information technology systems, and
financial management systems).
(6) Identify other organization(s) that will participate in the
proposed project. Describe their roles and responsibilities and
demonstrate their commitment to all five COVID-19 projects.
(7) Describe how project continuity will be maintained if there is
a change in the operational environment (e.g., staff turnover, change
in project leadership, etc.) to ensure project stability over the life
of the grant.
(8) Provide a list of staff positions for the project and other key
personnel, showing the role of each and their level of effort and
qualifications for all five COVID-19 projects. Key personnel include
the Chief Executive Officer or Executive Director, Chief Financial
Officer, Deputy Director, and Information Officer.
(9) Demonstrate successful project implementation for the level of
effort budgeted for the project staff and other key staff.
(10) Include position descriptions as attachments to the
application for all key personnel. Position descriptions should not
exceed one page each.
(11) For individuals who are currently on staff, include a
biographical sketch with their name for each individual that will be
listed as the project staff and other key positions. Describe the
experience of identified staff in all five COVID-19 projects. Include
each biographical sketch as an attachment to the project proposal/
application. Biographical sketches should not exceed one page per staff
member. Do not include any of the following:
(a) Personally Identifiable Information (social security number and
date and place or birth);
(b) Resumes; or
(c) Curriculum Vitae.
D. Performance Measurement Plan and Evaluation (20 Points)
Describe key performance indicators to monitor activities under all
five COVID-19 projects, explain measurable progress toward program
goals and objectives by incorporating processes and outcomes with
quarterly timelines, and advising on future program decisions through
evaluating success at reaching targets over the 2-year project period.
Describe how issues affecting progress will be addressed during the
project period and sequence in which they will be addressed. Identify
what approaches and strategies will be used to address issues and how
relevant information will be transmitted to specified target audiences
and used to enhance project activities and advance the program.
(1) Describe proposed COVID-19 data collection efforts (performance
measures and associated data) and how you will use the data to answer
evaluation questions. Evaluation questions may include, were activities
implemented as planned? Did activities meet measurable targets? Did
activities reach target population and how do you know?
This should include a logic model with data collection method, data
source, data measurement tool, identified staff for data management,
and data collection timeline.
(2) Identify key program partners and describe how they will
participate in the implementation of the evaluation plan (e.g., Tribal
Epidemiology Centers, universities, etc.).
(3) Describe how evaluating findings will be used at the applicant
level. Discuss how data collected (e.g., performance measurement data)
will be used and shared by the key program partners.
(4) Discuss any barriers or challenges expected for implementing
the plan, collecting data (e.g., responding to performance measures),
and reporting on evaluation results. Describe how these potential
barriers would be overcome. In addition, applicants may also describe
other measures to be developed or additional data sources and data
collection methods that applicant will use.
E. Budget and Budget Narrative (10 Points)
(1) Include a line item budget for all five COVID-19 projects
including expenditures identifying reasonable and allowable costs
necessary to accomplish the goals and objectives as outlined in the
project narrative for budget year one only.
(2) Provide a categorized budget for all five COVID-19 projects. If
it is anticipated that there will be travel costs to cover the cost of
staff and UIO leaders' attendance at national advisory committees and
workgroups, the applicant should ensure the associated travel costs are
included in the categorized budget for public policy.
(3) Ensure that the budget and budget narrative are aligned with
the project narrative. Questions to address include: What resources are
needed to successfully carry out and manage the five COVID-19 projects?
What other resources are available from the organization? Will new
staff be recruited? Will outside contractors/consultants be required?
(4) Include the total cost for any outside contractors/consultants
broken down by activity within each core project.
(5) If indirect costs are claimed, indicate and apply the current
negotiated rate to the budget. Include a copy of the current negotiated
IDC rate agreement in the appendix.
Multi-Year Project Requirements
Applications must include a brief project narrative and budget (one
additional page per year) addressing the developmental plans for each
additional year of the project. This attachment will not count as part
of the project narrative or the budget narrative.
Additional documents can be uploaded as Appendix Items in
Grants.gov:
Work plan.
Logic model.
Timeline with proposed objectives.
Position descriptions for key staff.
Resumes of key staff that reflect current duties.
Consultant or contractor proposed scope of work and letter
of commitment (if applicable).
Current Indirect Cost Rate Agreement.
Organizational chart.
Additional documents to support narrative (i.e., data
tables, key news articles, etc.).
2. Review and Selection
Each application will be prescreened for eligibility and
completeness as outlined in the funding announcement. Applications that
meet the eligibility criteria shall be reviewed for merit by the
Objective Review Committee (ORC) based on evaluation criteria.
Incomplete applications and applications that are not responsive to the
administrative thresholds will not be referred to the ORC and will not
be funded. The applicant will be notified of this determination.
Applicants must address all program requirements and provide all
required documentation.
3. Notifications of Disposition
All applicants will receive an Executive Summary Statement from the
IHS OUIHP within 30 days of the conclusion of the ORC outlining the
strengths and weaknesses of their application. The summary statement
will be sent to the Authorizing Official
[[Page 65843]]
identified on the face page (SF-424) of the application.
A. Award Notices for Funded Applications
The Notice of Award (NoA) is the authorizing document for which
funds are dispersed to the approved entities and reflects the amount of
Federal funds awarded, the purpose of the grant, the terms and
conditions of the award, the effective date of the award, and the
budget/project period. Each entity approved for funding must have a
user account in GrantSolutions in order to retrieve the NoA. Please see
the Agency Contacts list in Section VII for the systems contact
information.
B. Approved but Unfunded Applications
Approved applications not funded due to lack of available funds
will be held for one year. If funding becomes available during the
course of the year, the application may be reconsidered.
Note: Any correspondence other than the official NoA executed by an
IHS grants management official announcing to the project director that
an award has been made to their organization is not an authorization to
implement their program on behalf of the IHS.
VI. Award Administration Information
1. Administrative Requirements
Cooperative agreements are administered in accordance with the
following regulations and policies:
A. The criteria as outlined in this program announcement.
B. Administrative Regulations for Grants:
Uniform Administrative Requirements for HHS Awards,
located at 45 CFR part 75.
C. Grants Policy:
HHS Grants Policy Statement, Revised 01/07.
D. Cost Principles:
Uniform Administrative Requirements for HHS Awards, ``Cost
Principles,'' located at 45 CFR part 75, subpart E.
E. Audit Requirements:
Uniform Administrative Requirements for HHS Awards,
``Audit Requirements,'' located at 45 CFR part 75, subpart F.
2. Indirect Costs
This section applies to all recipients that request reimbursement
of indirect costs (IDC) in their application budget. In accordance with
HHS Grants Policy Statement, Part II-27, IHS requires applicants to
obtain a current IDC rate agreement, and submit it to DGM, prior to DGM
issuing an award. The rate agreement must be prepared in accordance
with the applicable cost principles and guidance as provided by the
cognizant agency or office. A current rate covers the applicable grant
activities under the current award's budget period. If the current rate
agreement is not on file with the DGM at the time of award, the IDC
portion of the budget will be restricted. The restrictions remain in
place until the current rate agreement is provided to the DGM.
Available funds are inclusive of direct and appropriate indirect
costs. Approved indirect funds are awarded as part of the award amount,
and no additional funds will be provided.
Generally, IDC rates for IHS grantees are negotiated with the
Division of Cost Allocation (DCA) https://rates.psc.gov/ or the
Department of the Interior (Interior Business Center) https://ibc.doi.gov/ICS/tribal. For questions regarding the indirect cost
policy, please call the Grants Management Specialist listed under
``Agency Contacts'' or the main DGM office at (301) 443-5204.
3. Reporting Requirements
The grantee must submit required reports consistent with the
applicable deadlines. Failure to submit required reports within the
time allowed may result in suspension or termination of an active
grant, withholding of additional awards for the project, or other
enforcement actions such as withholding of payments or converting to
the reimbursement method of payment. Continued failure to submit
required reports may result in one or both of the following: (1) The
imposition of special award provisions; and (2) the non-funding or non-
award of other eligible projects or activities. This requirement
applies whether the delinquency is attributable to the failure of the
awardee organization or the individual responsible for preparation of
the reports. Per DGM policy, all reports are required to be submitted
electronically by attaching them as a ``Grant Note'' in GrantSolutions.
Personnel responsible for submitting reports will be required to obtain
a login and password for GrantSolutions. Please see the Agency Contacts
list in Section VII for the systems contact information.
The reporting requirements for this program are noted below.
A. Progress Reports
Program progress reports are required quarterly, within 30 days
after the budget period ends (specific dates will be listed in the NoA
Terms and Conditions). These reports must include a brief comparison of
actual accomplishments to the goals established for the period, a
summary of progress to date or, if applicable, provide sound
justification for the lack of progress, and other pertinent information
as required. A final report must be submitted within 90 days of
expiration of the period of performance.
B. Financial Reports
Federal Financial Report (FFR or SF-425), Cash Transaction Reports
are due 30 days after the close of every calendar quarter to the
Payment Management Services, HHS at https://pms.psc.gov. The applicant
is also requested to upload a copy of the FFR (SF-425) into our grants
management system, GrantSolutions. Failure to submit timely reports may
result in adverse award actions blocking access to funds.
Grantees are responsible and accountable for accurate information
being reported on all required reports: The Progress Reports and
Federal Financial Report.
C. Federal Sub-Award Reporting System (FSRS)
This award may be subject to the Transparency Act sub-award and
executive compensation reporting requirements of 2 CFR part 170.
The Transparency Act requires the OMB to establish a single
searchable database, accessible to the public, with information on
financial assistance awards made by Federal agencies. The Transparency
Act also includes a requirement for recipients of Federal grants to
report information about first-tier sub-awards and executive
compensation under Federal assistance awards.
IHS has implemented a Term of Award into all IHS Standard Terms and
Conditions, NoAs and funding announcements regarding the FSRS reporting
requirement. This IHS Term of Award is applicable to all IHS grant and
cooperative agreements issued on or after October 1, 2010, with a
$25,000 sub-award obligation dollar threshold met for any specific
reporting period. Additionally, all new (discretionary) IHS awards
(where the period of performance is made up of more than one budget
period) and where: (1) The period of performance start date was October
1, 2010 or after, and (2) the primary awardee will have a $25,000 sub-
award obligation dollar threshold during any specific reporting period
will be required to address the FSRS reporting.
For the full IHS award term implementing this requirement and
additional award applicability information, visit the DGM Grants
[[Page 65844]]
Policy website at https://www.ihs.gov/dgm/policytopics/.
D. Compliance With Executive Order 13166 Implementation of Services
Accessibility Provisions for All Grant Application Packages and Funding
Opportunity Announcements
Recipients of Federal financial assistance (FFA) from HHS must
administer their programs in compliance with Federal civil rights laws
that prohibit discrimination on the basis of race, color, national
origin, disability, age and, in some circumstances, religion,
conscience, and sex. This includes ensuring programs are accessible to
persons with limited English proficiency. The HHS Office for Civil
Rights provides guidance on complying with civil rights laws enforced
by HHS. Please see https://www.hhs.gov/civil-rights/for-providers/provider-obligations/ and https://www.hhs.gov/ocr/civilrights/understanding/section1557/.
Recipients of FFA must ensure that their programs are
accessible to persons with limited English proficiency. HHS provides
guidance to recipients of FFA on meeting their legal obligation to take
reasonable steps to provide meaningful access to their programs by
persons with limited English proficiency. Please see https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/fact-sheet-guidance/ and https://www.lep.gov. For further guidance on providing culturally and
linguistically appropriate services, recipients should review the
National Standards for Culturally and Linguistically Appropriate
Services in Health and Health Care at https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=2&lvlid=53.
Recipients of FFA also have specific legal obligations for
serving qualified individuals with disabilities. Please see https://www.hhs.gov/ocr/civilrights/understanding/disability/.
HHS funded health and education programs must be
administered in an environment free of sexual harassment. Please see
https://www.hhs.gov/civil-rights/for-individuals/sex-discrimination/; https://www2.ed.gov/about/offices/list/ocr/docs/shguide.html; and https://www.eeoc.gov/eeoc/publications/fs-sex.cfm.
Recipients of FFA must also administer their programs in
compliance with applicable Federal religious nondiscrimination laws and
applicable Federal conscience protection and associated anti-
discrimination laws. Collectively, these laws prohibit exclusion,
adverse treatment, coercion, or other discrimination against persons or
entities on the basis of their consciences, religious beliefs, or moral
convictions. Please see https://www.hhs.gov/conscience/conscience-protections/ and https://www.hhs.gov/conscience/religious-freedom/.
Please contact the HHS Office for Civil Rights for more information
about obligations and prohibitions under Federal civil rights laws at
https://www.hhs.gov/ocr/about-us/contact-us/ or call 1-800-
368-1019 or TDD 1-800-537-7697.
E. Federal Awardee Performance and Integrity Information System
(FAPIIS)
The IHS is required to review and consider any information about
the applicant that is in the Federal Awardee Performance and Integrity
Information System (FAPIIS), at https://www.fapiis.gov, before making
any award in excess of the simplified acquisition threshold (currently
$250,000) over the period of performance. An applicant may review and
comment on any information about itself that a Federal awarding agency
previously entered. IHS will consider any comments by the applicant, in
addition to other information in FAPIIS in making a judgment about the
applicant's integrity, business ethics, and record of performance under
Federal awards when completing the review of risk posed by applicants
as described in 45 CFR 75.205.
As required by 45 CFR part 75 Appendix XII of the Uniform Guidance,
non-Federal entities (NFEs) are required to disclose in FAPIIS any
information about criminal, civil, and administrative proceedings, and/
or affirm that there is no new information to provide. This applies to
NFEs that receive Federal awards (currently active grants, cooperative
agreements, and procurement contracts) greater than $10,000,000 for any
period of time during the period of performance of an award/project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the Uniform Guidance, and the HHS
implementing regulations at 45 CFR part 75, the IHS must require a non-
Federal entity or an applicant for a Federal award to disclose, in a
timely manner, in writing to the IHS or pass-through entity all
violations of Federal criminal law involving fraud, bribery, or
gratuity violations potentially affecting the Federal award.
Submission is required for all applicants and recipients, in
writing, to the IHS and to the HHS Office of Inspector General all
information related to violations of Federal criminal law involving
fraud, bribery, or gratuity violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human Services, Indian Health Service,
Division of Grants Management, ATTN: Paul Gettys, Acting Director, 5600
Fishers Lane, Mail Stop: 09E70, Rockville, MD 20857, (Include
``Mandatory Grant Disclosures'' in subject line), Office: (301) 443-
5204, Fax: (301) 594-0899, Email: [email protected]
And
U.S. Department of Health and Human Services, Office of Inspector
General, ATTN: Mandatory Grant Disclosures, Intake Coordinator, 330
Independence Avenue SW, Cohen Building, Room 5527, Washington, DC
20201, URL: https://oig.hhs.gov/fraud/report-fraud/ (Include
``Mandatory Grant Disclosures'' in subject line), Fax: (202) 205-0604
(Include ``Mandatory Grant Disclosures'' in subject line) or Email:
[email protected]
Failure to make required disclosures can result in any of the
remedies described in 45 CFR 75.371. Remedies for noncompliance,
including suspension or debarment (see 2 CFR parts 180 & 376).
VII. Agency Contacts
1. Questions on the programmatic issues may be directed to: Shannon
Beyale, Health System Specialist, Office of Urban Indian Health
Programs, 5600 Fishers Lane, Mail Stop: 08E65D, Rockville, MD 20857,
Phone: (301) 945-3657, Fax: (301) 443-8446, Email:
[email protected].
2. Questions on grants management and fiscal matters may be
directed to: Donald Gooding, Grants Management Specialist, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville, MD 20857, Phone: (301) 443-2298,
Fax: (301) 594-0899, Email: [email protected].
3. Questions on systems matters may be directed to: Paul Gettys,
Acting Director, 5600 Fishers Lane, Mail Stop: 09E70, Rockville, MD
20857, Phone: (301) 443-2114; or the DGM main line (301) 443-5204, Fax:
(301) 594-0899, Email: [email protected].
VIII. Other Information
The Public Health Service strongly encourages all grant,
cooperative agreement and contract recipients to provide a smoke-free
workplace and
[[Page 65845]]
promote the non-use of all tobacco products. In addition, Public Law
103-227, the Pro-Children Act of 1994, prohibits smoking in certain
facilities (or in some cases, any portion of the facility) in which
regular or routine education, library, day care, health care, or early
childhood development services are provided to children. This is
consistent with the HHS mission to protect and advance the physical and
mental health of the American people.
Michael D. Weahkee,
RADM, Assistant Surgeon General, U.S. Public Health Service, Director,
Indian Health Service.
[FR Doc. 2020-22940 Filed 10-15-20; 8:45 am]
BILLING CODE 4165-16-P